Peripheral Arterial Disease Concept

subject area of

• A MultiCenter Pilot Randomized Controlled Trial of Remote Ischemic Preconditioning in Major Vascular Surgery  Academic Article
• A National Canadian Survey of Antithrombotic Therapy After Urgent and Emergent Limb Revascularization  Academic Article
• Anticoagulation therapy in 2015: where we are and where we are going  Academic Article
• Antithrombotic Agents  Academic Article
• Antithrombotic Therapy for Peripheral Artery Disease  Academic Article
• Antithrombotics in stable peripheral artery disease  Academic Article
• Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus  Academic Article
• Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis  Academic Article
• COMPASS for Vascular Surgeons  Academic Article
• Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up  Academic Article
• Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk  Academic Article
• Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1  Academic Article
• Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial  Academic Article
• Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease  Academic Article
• Consensus Document on Intermittent Claudication from the Central European Vascular Forum (C.E.V.F.)-3rd revision (2013) with the sharing of the Mediterranean League of Angiology and Vascular Surgery, and the North Africa and Middle East Chapter of International Union of Angiology.  Academic Article
• Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial  Academic Article
• Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence  Academic Article
• Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial  Academic Article
• Effects of basal insulin glargine and omega‐3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial  Academic Article
• Effects of the dual peroxisome proliferator–activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes  Academic Article
• Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease  Academic Article
• Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease  Academic Article
• External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry  Academic Article
• External applicability of the COMPASS trial: the Western Denmark Heart Registry  Academic Article
• Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease  Academic Article
• How can the results of the COMPASS trial benefit patients with coronary or peripheral artery disease in Poland?  Academic Article
• Impact of Arterial Procedures on Coagulation and Fibrinolysis – A Pilot Study  Academic Article
• Inclusion of People With Peripheral Artery Disease in Cardiac Rehabilitation Programs: A Pan-Canadian Survey  Academic Article
• Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy  Academic Article
• Leukotrienes biosynthesis in vascular surgery patients during perioperative period.  Academic Article
• Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial  Academic Article
• Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease  Academic Article
• Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin  Academic Article
• Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease  Academic Article
• Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: a prospective observational cohort study  Academic Article
• New developments in anticoagulants: Past, present and future  Academic Article
• Outcome of aortoiliac, femoropopliteal and infrapopliteal endovascular interventions in lesions categorised by TASC classification  Academic Article
• Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia  Academic Article
• Patients with Peripheral Artery Disease in the COMPASS Trial  Academic Article
• Perioperative cardiovascular complications rate and activity of coagulation and fibrinolysis among patients undergoing vascular surgery for peripheral artery disease and abdominal aortic aneurysm  Academic Article
• Position Statement on Noninvasive Imaging of Peripheral Arterial Disease by the Society of Interventional Radiology and the Canadian Interventional Radiology Association  Academic Article
• Prevalence of peripheral arterial disease diagnosed by ankle brachial index among chronic kidney disease patients in a tertiary care unit  Academic Article
• Prevention and Management of Urgent/Emergent Limb Ischemia  Academic Article
• Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)  Academic Article
• Real-Time Quantitative Measurements of Foot Perfusion in Patients With Critical Limb Ischemia  Academic Article
• Review of aspirin and clopidogrel resistance in peripheral arterial disease  Academic Article
• Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial  Academic Article
• Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction  Academic Article
• Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease  Academic Article
• Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization  Academic Article
• Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios  Academic Article
• Rivaroxaban for the prevention of major adverse cardiovascular events in patients with coronary or peripheral artery disease  Academic Article
• Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment  Academic Article
• Rivaroxaban in Peripheral Artery Disease after Revascularization  Academic Article
• Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial  Academic Article
• Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization  Academic Article
• Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin  Academic Article
• Stroke Outcomes in the COMPASS Trial  Academic Article
• Subintimal recanalization of peripheral chronic occlusive arterial disease with modified transseptal needle  Academic Article
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease  Academic Article
• The Time Has Come for Vascular Medicine in Canada  Academic Article
• The evolving treatment of peripheral arterial disease: preventing ischaemic events in the post-COMPASS era  Academic Article
• The use of local anesthesia to perform lower limb revascularization in the fragile patient with critical limb ischemia.  Academic Article
• Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study  Academic Article
• Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease  Academic Article
• Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease  Academic Article
• Women and Peripheral Arterial Disease: A Review of Sex Differences in Epidemiology, Clinical Manifestations, and Outcomes  Academic Article
• Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both  Academic Article
• miR-29c-3p is an Effective Biomarker of Abdominal Aortic Aneurysm in Patients Undergoing Elective Surgery  Academic Article